BIOMX INC's ticker is PHGE and the CUSIP is 09090D103. A total of 12 filers reported holding BIOMX INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $54,000 | -77.5% | 158,655 | -51.7% | 0.00% | -50.0% |
| Q2 2022 | $240,000 | -61.2% | 328,655 | +2.5% | 0.00% | -60.0% |
| Q1 2022 | $619,000 | +262.0% | 320,655 | +200.5% | 0.01% | +400.0% |
| Q4 2021 | $171,000 | -75.3% | 106,696 | -52.7% | 0.00% | -80.0% |
| Q3 2021 | $691,000 | -64.7% | 225,696 | -37.1% | 0.01% | -61.5% |
| Q2 2021 | $1,960,000 | -23.3% | 359,000 | 0.0% | 0.01% | -23.5% |
| Q1 2021 | $2,556,000 | – | 359,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Johnson & Johnson Innovation - JJDC, Inc. | 2,133,402 | $11,648,000 | 1.19% |
| MMCAP International Inc. SPC | 684,451 | $3,737,000 | 0.18% |
| Orbimed Advisors | 2,313,489 | $12,632,000 | 0.13% |
| Taylor Wealth Management Partners | 31,804 | $174,000 | 0.06% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 14,207 | $78,000 | 0.04% |
| ROYCE & ASSOCIATES LP | 359,000 | $1,960,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 104,000 | $568,000 | 0.01% |
| J. Goldman & Co LP | 150,000 | $92,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 427,702 | $2,335,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,060 | $6,000 | 0.00% |